Status: Not yet recruiting
Panuri Performance Study
The main purpose of the study is to assess the performance of the Panuri test in detecting pancreatic ductal adenocarcinoma (PDAC) the most common type of pancreatic cancer that accounts for approximately 90% of all pancreatic cancer cases. The study aims to characterize the performance of the Panuri test in detecting pancreatic ductal adenocarcinoma in patients with symptoms supporting a clinical suspicion of pancreatic cancer The Panuri test is intended for professional laboratory use for diagnostic purposes.
Participants needed: 1,100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Urteste S.AUpdated: May 14, 2026Locations: 28
Eligibility criteria
Adults 18 years and older [+3]
For subjects in the enriched arm, imaging results are highly suspicious for non-... [+14]